Publication | Open Access
KRAS mutations in cell-free DNA from preoperative and postoperative sera as a pancreatic cancer marker: a retrospective study
97
Citations
20
References
2018
Year
Changes in KRAS mutation status between preoperative and postoperative cfDNA may be a useful predictive biomarker for survival and treatment response.
| Year | Citations | |
|---|---|---|
Page 1
Page 1